Anti-TNF monoclonal antibody inhibiting TNFa; Phase 2 trial

• Inclusion:
• Pulmonary sarcoidosis with & without extrapulmonary manifestations, diagnosed w/in 3m, on CS 7.5 to 25 mg daily, Non-TNFi DMARDs (MTX, AZA, etc) for 3m